Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
South San Francisco
10–100
Companies
More info
Related cities
New York
San Francisco
Atlanta
Austin
Boston
Chicago
Dallas
Los Angeles
Seattle
Palo Alto
San Diego
Mountain View
Redwood City
Menlo Park
Portland
Cambridge
Boulder
Santa Monica
San Jose
San Mateo
Sunnyvale
Santa Clara
St Louis
Denver
Cincinnati
Berkeley
Philadelphia
Irvine
Washington, D.C.
Las Vegas
Houston
Madison
Nashville
Memphis
Minneapolis
Pittsburgh
Oakland
San Antonio
Salt Lake City
Miami
10–100 companies in South San Francisco
Show all
Genentech
Biotechnology
MyoKardia
Biotechnology
insitro
Biotechnology +2
Freenome
Personal Health +2
SuccessFactors
Enterprise Software +3
Plenty
Big Data +2
Sutro Biopharma
Biotechnology
Theravance
Biotechnology
Dispatch
Robotics +2
Counsyl
Machine Learning +3
Kinestral Technologies, Inc.
Hardware +1
CytoVale
Biotechnology
Veracyte, Inc.
Health Care +1
Principia Biopharma
Biotechnology
Titan Pharma
Medical +1
All companies in South San Francisco
News
Funding rounds
Acquisitions
Companies
Investors
Filter companies
Companies
58
Growing
Add companies
Deals 2020 Q4
1
investment
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Upgrade account
neurons.AI
BMS joins forces with insitro to develop neurodegenerative treatments
neurons.AI
insitro Bolsters Machine–Learning Platform with Haystack Sciences Acquisition
neurons.AI
Koller’s insitro snaps up Haystack to build up machine learning tech
$140,000,000
Venture capital (Series D)
TechCrunch
Plenty has raised over $500 million to grow fruits and veggies indoors
Xconomy
Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B
Xconomy
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More
$270,000,000
Venture capital (Series C)
FinSMEs
,
ChinaMoneyNetwork
Freenome Closes $270M Series C Financing
Xconomy
Genentech Gets FDA OK for Injectable Rare Neuroimmune Disease Drug
Xconomy
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia
$135,000,000
Venture capital (Series D)
FinSMEs
,
Pulse 2.0
Encoded Therapeutics Raises $135M in Series D Financing
$143,000,000
Venture capital (Series B)
FinSMEs
,
neurons.AI
,
PrivateEquityWire
, +1
insitro Raises $143M in Series B Financing
$60,000,000
Venture capital (Series A)
WSJ Venture Capital
,
FinSMEs
Cancer Drugmaker Day One Biopharmaceuticals Launches With $60 Million
the home of AI info
Scientist, Neuroscience : South San Francisco | Genentech RnD Jobs
Xconomy
MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021
TechCrunch
The Dispatch, a news organization built on Substack, passes $1M in annual revenue
Xconomy
Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact
the home of AI info
Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...
the home of AI info
Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...
$15,000,000
Venture capital (Series B)
the home of AI info
,
the home of AI info
Business Briefs: Cytovale Announces $15 Million in Financing
the home of AI info
Roche/Genentech Partnering Team: One Face For The World To See